Uganda’s Dei BioPharma secures patents for Ebola ,Mpox mRNA vaccines
Ugandan biotechnology firm Dei BioPharma has secured new patents for Ebola and Mpox vaccines, signaling a major step toward Africa’s ...
Tag: mRNA technology.
Museveni praises Dei Biopharma’s Dr.Magoola for securing US patent for Cancer treatment
President Museveni has today commended Ugandan scientist Dr. Mathias Magoola for securing a United States patent for cancer treatment, describing ...
Dei BioPharma’s Dr. Matthias Magoola invents first universal foot and mouth disease vaccine
Dr. Matthias Magoola, the founder and Managing Director of Dei BioPharma, has received recognition from the United States Patent and ...
Dei Biopharma’s Dr.Magoola wins international award for groundbreaking vaccine research
Dr. Matthias Magoola, founder and Managing Director of Dei Biopharma Ltd, has received the prestigious Best Researcher Award at the ...
MPs urge Dei Biopharma to enhance research for emerging Tropical Diseases
Members of Parliament on the Health Committee have called on Dei Biopharma vaccines manufacturing plant in Matugga, Wakiso district to ...
Join us on this journey as we continue to be your trusted source for the bold, accurate, and authoritative news, information, and knowledge you need to stay informed, engaged, and inspired. Uganda's stories are worth telling, and UG Bulletin is here to bring them to you.
